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Abstract
Background: MicroRNAs (miRNAs) are small ~22 nucleotide non-coding RNAs that function as post-transcriptional
regulators of messenger RNA (mRNA) through base-pairing to 6–8 nucleotide long target sites, usually located
within the mRNA 3’ untranslated region. A common approach to validate and probe microRNA-mRNA interactions
is to mutate predicted target sites within the mRNA and determine whether it affects miRNA-mediated activity. The
introduction of miRNA target site mutations, however, is potentially problematic as it may generate new,
“illegitimate sites” target sites for other miRNAs, which may affect the experimental outcome. While it is possible to
manually generate and check single miRNA target site mutations, this process can be time consuming, and
becomes particularly onerous and error prone when multiple sites are to be mutated simultaneously. We have
developed a modular Java-based system called ImiRP (Illegitimate miRNA Predictor) to solve this problem and to
facilitate miRNA target site mutagenesis.
Results: The ImiRP interface allows users to input a sequence of interest, specify the locations of multiple predicted
target sites to mutate, and set parameters such as species, mutation strategy, and disallowed illegitimate target site
types. As mutant sequences are generated, ImiRP utilizes the miRBase high confidence miRNA dataset to identify
illegitimate target sites in each mutant sequence by comparing target site predictions between input and mutant
sequences. ImiRP then assembles a final mutant sequence in which all specified target sites have been mutated.
Conclusions: ImiRP is a mutation generator program that enables selective disruption of specified miRNA target
sites while ensuring predicted target sites for other miRNAs are not inadvertently created. ImiRP supports
mutagenesis of single and multiple miRNA target sites within a given sequence, including sites that overlap. This
software will be particularly useful for studies looking at microRNA cooperativity, where mutagenesis of multiple
microRNA target sites may be desired. The software is available at imirp.org and is available open source for
download through GitHub (https://github.com/imirp).
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Background
MicroRNAs (miRNAs) are 21-25 nucleotide non-
coding RNAs that provide rapid repression of target
gene expression. This repression is initiated through
miRNA base pairing to complementary target sites
usually located within messenger RNA (mRNA) 3’
untranslated region (3’UTR) [1, 2]. Computational and
experimental evidence suggest that the 5’ end of the
miRNA, the miRNA “seed”, is most important for me-
diating miRNA-target interactions [3–7]. The miRNA
seed recognizes a complementary target site in the
mRNA, which can range from six to eight nucleotides
in length [2]. MiRNAs act as sequence-specific guides
that recruit protein silencing complexes and destabilize
the mRNA and/or interfere with translation [8], and
thereby provide a mechanism for either silencing or
fine-tuning the translation of target mRNAs [9, 10].
Short RNA deep-sequencing data has identified over
15000 miRNA gene loci and over 17000 mature miRNA
sequences in 142 species. Specifically, over 2500 and 1900
distinct mature miRNA sequences have been identified in
human and mouse, respectively [11]. Computational ap-
proaches that take into account evolutionary conservation
of predicted target sites suggest that over 60 % of human
protein-coding genes are targeted by miRNAs [12], while
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other computational methods using pattern-based ap-
proaches for predicting miRNA-target heteroduplexes es-
timate that over 90 % of mammalian gene transcripts are
directly regulated by miRNAs [13]. In addition, a growing
body of evidence reveals that miRNAs play important
roles during animal development [14] and almost every
cellular process investigated has been shown to involve
participation of miRNA regulation [10]. Due to their abil-
ity to impose rapid and tight control of gene expression,
miRNAs represent an important regulatory mechanism
for development and disease.
Many computational tools have been developed for
studying miRNAs. For example, several of programs are
available to address challenges associated with miRNA
discovery [15, 16] and numerous applications enable iden-
tification of miRNA target sites in mRNAs [3, 12, 13, 17–
26]. MicroRNA target site prediction programs make use
of a number of different parameters in their predictions,
such as extent of complementarity to the miRNA 5’ end,
hybridization energy of the mRNA-miRNA heteroduplex,
evolutionary conservation of predicted target sites, mRNA
secondary structure, and local 3’UTR context. Addition-
ally, other software tools are available for predicting the
impact of 3’UTR SNPs on miRNA binding [26], for asses-
sing the impact of mutations in miRNA genes [27], and
for comparing the predicted set of target genes for two
different miRNAs [27].
Currently, no software is available for generating muta-
tions to disrupt predicted miRNA target sites in a given
mRNA sequence. For example, although the program
“mrSNP”, was designed to take known SNPs for a given
3’UTR as input and assesses whether these SNPs could
affect miRNA binding on the other hand, it is not a muta-
tion generator program and does not have the capacity to
generate random mutations. Generating such mutations,
however, is an important approach for examining miRNA-
mRNA interactions experimentally. Mutating a predicted
miRNA target site is commonly used in reporter-based
approach experiments to determine whether a predicted
target site can, in fact, be regulated by a candidate miRNA.
In addition, mutations that disrupt one or more miRNA
target sites in a given 3’ UTR can be used to examine the
biological relevance of the target site(s) in question. One
problem that can arise when a target site is mutated is that
the mutation itself can create a new or “illegitimate”
microRNA target site (Fig. 1). If the miRNA that targets
the illegitimate site is present in the cell being used in the
experiment, it could confound the data. Therefore, care
must be taken when devising a mutation strategy to check
that target site mutations do not inadvertently create new
miRNA target sites.
Our goal was to develop a modular, open source appli-
cation that could be run through a web interface or
downloaded and adapted to specialized projects. We
have created a Java-based system called ImiRP (Illegitim-
ate miRNA Predictor) to generate miRNA target site
mutations in any sequence of interest and address the
problem of illegitimate miRNA target site creation.
Users input a DNA or RNA sequence and specify the lo-
cation of predicted miRNA target sites to be mutated.
ImiRP then automates the processes of mutation gener-
ation, illegitimate miRNA target site identification, and
synthesis of a final mutant sequence lacking new pre-
dicted miRNA target sites. ImiRP is a particularly useful
tool when investigating regulation of a single mRNA 3’
UTR by multiple miRNAs, where situations such as tar-
get site overlap makes mutagenesis design more challen-
ging to perform manually.
Implementation
Input user interface
The ImiRP user interface showing examples of input
and output are shown in Figs. 2 and 6. A detailed set of
instructions, “How to use ImiRP” is appended in the
Fig. 1 The problem associated with miRNA target site mutagenesis. A wild type 3’UTR sequence contains a predicted 7mer-m8 target site for
miR-7 (green). Mutation disrupts the interaction between miR-7 and its predicted target site, but creates an illegitimate 7mer-m8 target site for
miR-296-3p in the process (red)
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Fig. 2 (See legend on next page.)
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Additional file 1 section as well as on the imirp.org web-
site. After creating a new project, the user enters a DNA
or mRNA sequence of interest (i.e. 3’UTR) and specifies
the organism of interest. All animal species with mature
miRNA sequences available through miRBase version 21
(mirbase.org) are available for selection [11]. Users then
define the position(s) of predicted miRNA target sites(s)
to be mutated by selecting the nucleotide position of the
input sequence that is complementary to position 7 of
the targeting miRNA (Fig. 2a). ImiRP will then highlight
in bold lettering, a stretch of 6 nucleotides starting from
the nucleotide position that was entered, defining the
mRNA region, complementary to miRNA positions 2-7,
to be mutated (Fig. 2a). Thus, for 7mer-m8 target sites,
in which base pair complementarity occurs at miRNA
positions 2-8, the input nucleotide position that is com-
plementary to miRNA position 7 is entered in the “Mu-
tation Site” input window.
In designing ImiRP, we took into consideration the fact
that miRNA target sites vary in size and type (e.g. 6mer,
7mer-m8, 7mer-A1 or 8mer) [2, 12]. We chose this design
strategy for defining mutation sites two reasons: 1) To
keep ImiRP simple to use and to limit computational de-
mands of the software. MicroRNA seed site positions 2-7
are used for mRNA target recognition in all major target
site types [2, 12]. 2) Disrupting base pairing between
miRNA positions 2-7 and the mRNA target site by mutat-
ing multiple nucleotides in the target site has been shown
to interfere with repression [7, 28–31].
Upon defining the project parameters, the ImiRP user
interface allows researchers to specify mutation parame-
ters (Fig. 2b). The user can select the types of illegitim-
ate miRNA target sites, termed “invalid sites”, that they
wish to exclude from their mutant sequence. ImiRP can
identify five classes of miRNA target sites: 6mer, 7mer-
m8, 7mer-A1, 8mer, and offset 6mer (OS-6mer) [2, 12].
6mer seed sites are complementary to positions 2-7 of
the miRNA, 7mer-A1 sites are complementary to posi-
tions 2-7 and have an A across from miRNA position 1,
and 8mer sites are 7mer-m8 sites with an A across from
position 1 [12]. OS-6mer seed sites are complementary
to positions 3-8 of the miRNA [12]. ImiRP also recog-
nizes predicted target sites containing a single G:U base
pair. By manually selecting and using arrow buttons in
the user interface, invalid site types can be designated
(Fig. 2b). For instance, illegitimate perfect 6-8mer target
sites can be specified as invalid by moving them into the
select list entitled “Invalid Site Types”. In this case, the
result would be a final mutant sequence lacking newly
created perfect 6-8mer sites, but permitting newly created
6-8mer sites containing a single G:U wobble base pair. The
interface also enables the user to specify a desired mutation
strategy to be executed by selecting which nucleotide bases
to use for mutagenesis from a checklist. Selecting only
G will instruct ImiRP to generate mutant sequences by
making nucleotide changes within specified target sites to
G only. Using a drop down menu, the number of nucleo-
tide changes to introduce per specified miRNA target site,
Fig. 3 ImiRP Workflow. ImiRP can be divided into three major
modules. The Sequence Mutation module a feeds mutated
sequences into the Target Site Prediction module b, the results of
which are supplied to the Master Mutant Assembly module c to
optimize and output a final mutant sequence
(See figure on previous page.)
Fig. 2 ImiRP input user interface. a The user is first directed to create a project and specify project parameters. The project can be named, and in
this example we have named the project “ImiRP Test”. A DNA or RNA sequence must be input along with information about the species of
interest. The input sequence will be displayed for viewing. Finally, at least one “mutation site”, the region into which mutations will be introduced, is
specified by typing the sequence position complementary to miRNA position 7 into the textbox. All selected mutation sites, complementary to miRNA
positions 2-7, appear bolded in the displayed original input sequence for inspection. In this example, a segment of the mouse Pax6 3’UTR and three
hypothetical predicted target sites have been used as input. b Upon creation of a project, the user is asked to specify mutation parameters. In the
“Mutation Strategy” tab, nucleotides to use for mutation and number of nucleotide changes per specified mutation site can be selected. In the “Define
Invalid Sites” tab, users can specify the types of newly created miRNA target sites they do not want present in their final mutant sequence. In this case,
any mutant sequences provided as output will contain two adjacent nucleotide changes per specified target site using all four nucleotides for mutation,
and no mutant sequences containing newly created 8mer, 7mer-m8, or 7mer-A1 predicted target sites will be provided as output
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from two to six changes, can be designated. For
example, selecting “2 changes per site” will ensure that two
adjacent nucleotide changes are introduced into each se-
lected miRNA target site.
ImiRP workflow
Conceptually, ImiRP can be subdivided into three mod-
ules (Fig. 3):
i) Sequence mutation module
When ImiRP is run, information about the input
sequence, defined regions to mutate, and desired
mutation strategy are sent to the Sequence Mutation
module (Fig. 3a). This module first divides the input
sequence into “mutationally independent” regions
based on the spacing between miRNA target sites to
be mutated. Since the largest recognized miRNA
seed site is eight nucleotides [2], two predicted
target sites spaced at least seven nucleotides apart
can be mutated independent of one another without
generating an illegitimate target site that spans both
mutations. Simultaneously mutating two predicted
target sites spaced less than seven nucleotides apart
could generate a new target site for a different
miRNA containing mutated nucleotides from each
of the original target sites. Consequently, predicted
target sites spaced less than seven nucleotides apart
are grouped into a single independent region, and
each independent region is annotated based on the
positions of the first and last nucleotides of sites
within the region relative to start of the input
sequence (Fig. 4a). All specified sites within a given
independent region are mutated as a unit, while sites
within other regions are left unchanged. This process
is repeated for each independent region (Fig. 4b).
ii) Target site prediction module
Mutant 3’UTR sequences generated by the Sequence
Mutation module are sent to the Target Site
Prediction module (Fig. 3b). This module is
responsible for identifying predicted miRNA target
sites present in each mutant sequence that are
absent from the original input sequence. The
custom ImiRP miRNA prediction component uses
pattern recognition to identify regions of each
mutant 3’UTR sequence that are complementary to
the 5’ seed regions of known mature miRNAs. High
confidence FASTA-format miRNA sequences were
obtained from the most recent release of miRBase,
version 21 [11]. MiRBase defines a high confidence
miRNA sequence as having at least ten reads mapping
to each arm of the pre-miRNA, or having at least five
reads mapping to each arm and at least 100 reads in
total [11].
Following miRNA target site identification, the
prediction module compares the input sequence
target site predictions to predictions for each mutant
sequence. Information about predicted sites present
in each mutant sequence that are absent from the
input sequence (i.e. the illegitimate target sites) are
stored in a database along with the respective
mutant sequences (Fig. 5). Information in the
database is accessed by the Master Mutant
Assembly module (Fig. 3c) for synthesis of a final
mutant sequence.
iii)Master mutant assembly module
The Master Mutant Assembly module first
eliminates all mutant sequences containing
illegitimate miRNA target sites that were specified as
invalid through the user interface. This process is
repeated for each independent region. As valid
mutations for each region are generated, they are
displayed in an output user interface (Fig. 6). The
Fig. 4 The Sequence Mutation module. a The input sequence is
divided into “mutationally independent” regions. User-specified target
sites spaced less than 7 nucleotides apart are grouped into a single
independent region and are annotated based on the positions of the
first and last nucleotides of sites within the given region. b To reduce
computational overhead, sites within a given independent region are
mutated as a unit, while sites in other regions are unchanged
Fig. 5 The target site prediction module. Predicted miRNA target
sites within input and mutant sequences are identified using a
custom component that identifies predicted target sites based on
complementarity to the miRNA 5’ end. FASTA-format miRNA sequence
data was collected from miRBase version 21 [11]. Information about
predicted sites present in each mutant sequence that are absent from
the input sequence are stored in a database for analysis
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output interface displays up to five valid mutants for
each independent region, indicating the location of
specified six nucleotide “mutation sites” and mutated
nucleotides. Here, the user can select a single
desired mutant for each independent region and
ImiRP generates an assembled mutant sequence in
which all specified miRNA target sites have been
mutated without creating any illegitimate predicted
target sites of the types specified. A zip folder
containing four files is made available for download
through the output user interface. A project
information text file contains the assembled mutant
DNA sequence, and three CSV files contain
information about: i) miRNA target site predictions
for the input sequence, ii) miRNA target site
predictions for the assembled mutant sequence, and
iii) new predicted miRNA target sites present in the
mutant sequence. If any regions fail to generate valid
results, the user will be alerted to reprocess those
regions using a different mutation strategy.
Accumulated results from multiple mutation runs are
displayed in the results tab of the output user interface.
In the future, we plan to annotate each valid mutant
sequence displayed in the results with a “mutation run
identifier” so that it is clear which mutation parameters
were used to generate each sequence.
Project organization
ImiRP’s code is organized into two separate Scala Build
Tool (SBT) projects: ImiRP Core and ImiRP Web. ImiRP
Core contains the data model and the primary business
logic but has no presentation layer. Core functionality is
exposed through Java services and Akka actors, and
must be programmatically interacted with. ImiRP Web
depends on ImiRP Core and exposes the functionality of
ImiRP Core to an end user via a Web interface. This
multi-project organization scheme was chosen to keep
the presentation logic separate from the core business
logic, thus allowing ImiRP to support alternative core or
presentation implementations in the future. Additionally,
this organizational approach allows ImiRP to be run
headless (without a presentation layer) or to be inte-
grated with other projects or systems as a library.
Mutant sequence generation algorithm
ImiRP’s mutation generation algorithm is essentially a
random nucleotide sequence permutation generator. As
input, it accepts a DNA or RNA nucleotide sequence, a
list of sites, a set of allowable nucleotide types for muta-
genesis, number of allowable nucleotide changes per site,
a mutation region, and a callback. The algorithm iterates
over each site in the given independent mutation region
to apply nucleotide changes to each site. To accomplish
Fig. 6 ImiRP output user interface. Input mutation sites spaced less than seven nucleotides apart are grouped into independent regions and
each region is mutated independently of other regions. The output user interface displays up to five mutant sequences for each region that
satisfy the specified mutation parameters. For example, the output mutations for ImiRP Test (Fig. 2) will not have generated any new 8mer, 7mer-m8,
or 7mer-A1 predicted miRNA target sites. The original input sequence for each region is displayed above the mutants for comparison, and brackets
denote the bounds of each specified mutation site. The user must select one desired mutant for each region, and the changes are displayed as an
assembled mutant sequence. Once the selection process is complete, the user may download a folder containing information about their assembled
mutant sequence, and predicted miRNA target sites in the input and mutant sequences
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this, the algorithm selects a random nucleotide from the
list of allowable nucleotides and replaces the nucleotide
in the input sequence at the start of the site. This
process is repeated for subsequent nucleotides contained
within the given site. A mutant sequence is produced
once all sites have been processed in this way. Due to
the simplicity of this algorithm, some mutant sequences
will not satisfy all specified mutation criteria. As such,
all mutant sequences must be passed through a filter
that either accepts or rejects the mutant based on
whether it satisfies all criteria. Finally, if a mutant se-
quence is accepted by the filter, the callback is activated
and the mutant sequence is passed on for further pro-
cessing (see Additional file 1: Figure S2 for pseudocode).
MicroRNA target site prediction algorithm
The target site predictor uses a pattern matching algorithm
to detect miRNA seed matches to an input sequence. To
detect seed matches, the algorithm iterates over a list of
miRNA sequences, from the miRBase high confidence
database, and compares the first eight nucleotides (the 5’
end) of each miRNA entry for complementarity to the in-
put sequence. An entry is compared to a sequence by scan-
ning across the sequence using an eight nucleotide sliding
window. Before each advancement of the window, a hier-
archy of conditions are checked to determine whether a
seed match is present. If a seed match is found, the result is
stored, the window is advanced, and the process repeats
until the end of the sequence is reached.
The condition hierarchy begins by comparing the first
nucleotide (position 1) of the sequence window to the last
nucleotide of the miRNA 5’ end (position 8). If those nu-
cleotides are a match, the next five nucleotides (positions
2-6 of the sequence, positions 7-3 of the miRNA 5’ end)
are checked for matches. If any of these nucleotides are
not a match, no seed match is possible and the window
will advance. If they do match, then an 8mer, 7mer-m8, or
OS-6mer seed match is known to be present. The condi-
tion hierarchy is then further evaluated to check for a
match between sequence position 7 and miRNA position
2. If this match is not present, then an OS-6mer seed
match is identified. If this match is present, the seed
match is either an 8mer if the last nucleotide of the se-
quence window (position 8) is an adenosine, or it is a
7mer-m8 if the last nucleotide is not adenosine. If the first
nucleotide of the sequence window did not match miRNA
position 8, then only a 7mer-A1 or a 6mer seed match are
possible, given that sequence positions 2-7 and miRNA
positions 7-2 have been found to match. The seed match
is a 7mer-A1 if the last nucleotide of the sequence window
is adenosine, or the seed match is a 6mer if the last nu-
cleotide is not adenosine. Two nucleotides are considered
a match if the following conditions are true: the sequence
nucleotide is A and the miRNA 5’ end nucleotide is T/U
or vice versa, the sequence nucleotide is C and the
miRNA nucleotide is G or vice versa. If the user allowed
G:U pairs and if a G:U pair has not already been found,
two nucleotides will be considered a match if the sequence
nucleotide is T/U and the miRNA nucleotide is G or vice
versa (see Additional file 1: Figure S3 for pseudocode).
System architecture
ImiRP was developed in the Java programming language.
Java was chosen for its extensive catalogue of third party
libraries and for its cross-platform support.
ImiRP’s architecture is based on a model-view-controller
(MVC) architecture consisting of a view layer for presenting
information, a controller layer for applying business logic,
and a model layer for storing information. In its current
form, the view layer is driven by the Play Framework (Play)
and AngularJS. Play accepts incoming HTTP requests and
maps those requests to view templates. These view
templates are partially rendered by Play and then returned
as HTML and Javascript for final rendering by AngularJS
in a user’s browser. The controller layer is a shared respon-
sibility between ImiRP Web and ImiRP Core. ImiRP Web’s
portion of the controller layer is responsible for mapping
HTTP requests to ImiRP Core’s services and returning re-
sults from those services as rendered templates. Currently,
the model layer exists entirely within ImiRP Core, but this
may change in the future as ImiRP Web may require some
of its own models for features that are specific to
presentation.
miRBase data import
Currently, known miRNA data is imported from the
high confidence dataset (mature.fa) that is provided by
miRBase version 21. Mature.fa is a text file database of
FASTA-format, mature miRNA sequences. ImiRP parses
this database and imports it into its own internal format
for use by ImiRP’s target site predictor. To accomplish
this, an import utility that could read the mature.fa data-
set and import miRNAs was created. The import utility
was designed to allow alternative miRNA datasets to be
imported provided that they follow a similar FASTA for-
mat. This enables ImiRP to stay current as new miRNA
datasets become available. Presently, an alternative
miRNA dataset can only be used by altering ImiRP’s glo-
bal configuration file and restarting the application. In
future versions of ImiRP, we may enable use of custom
miRNA datasets that could be uploaded for specific pro-
jects. This way, each individual project could specify a
miRNA dataset that best meets its requirements.
Results and discussion
In order to facilitate the generation of miRNA target site
mutations in the mRNA 3’ UTR, we have designed ImiRP,
a program that automates the entire process of generating
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mutant sequences. A key feature of ImiRP is its ability to
suggest mutations that lack illegitimate miRNA target
sites as such sites have the potential to complicate experi-
ments aimed at examining miRNA-target regulation.
Computational time optimization
The number of sequences generated by the Sequence
Mutation module increases rapidly with increasing pre-
dicted target sites to mutate. Each of these mutant se-
quences then needs to be processed to identify any
illegitimate target sites generated. As a result, one prob-
lem that needed to be addressed in the implementation
of ImiRP was the large computational time required to
generate a final mutant sequence when mutating many
predicted miRNA target sites simultaneously. We imple-
mented several strategies below to address this problem:
i) Limit miRNA target site mutations to six nucleotide
motifs
Nucleotide changes introduced into the region
complementary to miRNA positions 2-7 have been
found to create the most significant reduction in
regulation by the targeting miRNA [28]. Additionally,
by limiting the problem space for target site
mutagenesis to six nucleotide regions, we were able to
reduce the number of possible mutant sequences and
thus the computation time. A limitation to this
approach is that some examples of “seedless” miRNA
target sites have been identified. These rely more
heavily on binding the 3’ end of the miRNA, or
contain mismatches or bulges between the miRNA
seed and its target [32, 33]. However, comparative
analysis of orthologous mRNAs suggests that target
sites complementary to the 5’ end of the miRNA are
more evolutionarily conserved than expected by chance
[12]. Additionally, mRNA and protein expression
analysis reveals that messages containing miRNA
seed matches are preferentially regulated by
miRNAs [5, 6]. As such, we decided to focus on an
approach that restricts mutagenesis to the six
nucleotide region complementary to miRNA
position 2-7.
ii) Introduce adjacent nucleotide changes per specified
seed site
Even in the presence of extensive 3’ pairing, single
nucleotide mismatches introduced into a miRNA
target site complementary to miRNA positions 2-7,
the core target site, have a large impact on target site
efficacy [28]. Based on these results, we reasoned that
a minimum of two nucleotide changes in this region
would effectively abolish regulation by the targeting
miRNA [28]. Additionally, requiring that nucleotide
changes be adjacent reduces the number of possible
mutants generated, improving processing speed, while
also reducing the number of illegitimate target sites
created by narrowing the region of sequence that is
altered. For an independent region containing three
non-overlapping predicted target sites, over 60 billion
different mutants are possible when any combination
of at least two nucleotides within a core target site are
mutated to any permutation of the four nucleotide
bases (Additional file 1: Figure S1-a). However, when
only two adjacent nucleotide changes are permitted per
site, the number of possible mutant sequences for an
independent region containing three non-overlapping
sites is reduced to approximately 90,000 (Additional
file 1: Figure S1-b). It should be noted that through the
input user interface, it is possible to select a mutation
strategy that will introduce more than two nucleotide
changes per specified target site.
iii)Divide the input sequence into independent regions
based on inter-site spacing
Since 8mer target sites are the largest recognized
sites [2], predicted miRNA target sites spaced seven
or more nucleotides apart can be mutated without
generating a new predicted miRNA target site that
spans both mutations. As such, sites spaced less
than seven nucleotides apart are grouped into
independent regions, and are all mutated as a unit.
Mutating one region at a time, while keeping the
remainder of the sequence unchanged, significantly
reduces the number of permutations of redundant
mutations that are generated (Additional file 1: Figure
S1-c) and dramatically improves processing speed.
Expanding on the above example, if two independent
regions containing three non-overlapping predicted
target sites are mutated together, over 8 billion mutant
sequences are possible. However, if these two regions
containing three sites each are mutated separately of
one another, approximately 180,000 mutant sequences
are possible (Additional file 1: Figure S1-d).
iv)Custom ImiRP miRNA target site prediction
component
Initially, we used the PITA executable in the Target Site
Prediction module. PITA assigns each predicted
miRNA target site a score based on the difference
between the free energy of miRNA-target duplex
formation and the cost of unpairing mRNA secondary
structure in the region of the predicted target site [23].
Though evidence suggests that miRNA target site
accessibility [23] and local target site environment
[34, 35] can impact target site efficacy, some evidence
also suggests that mRNA secondary structure is an
insufficient predictor of target site functionality [35].
Since we are primarily concerned with creating
illegitimate target sites having the potential to be
functional, this feature of the PITA target site
prediction component was not needed. ImiRP’s custom
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target site predictor uses only pattern recognition to
identify five types of target seed site (8mer, 7mer-m8,
7mer-A1, 6mer, OS-6mer) [2, 12] and is therefore less
computationally demanding, thus improving processing
time.
Though ImiRP is capable of identifying miRNA target
sequences, it is not recommended for use as a target
site prediction tool. Since it predicts miRNA seed
matches based only on sequence complementarity to
miRNA 5’ ends, it is an over-predicting tool and will
produce many false-positive predictions. Many superior
programs are available to address the problem of
miRNA target identification [3, 12, 13, 17–25].
v) Stop generating mutant sequence once five valid
mutants have been identified
The ImiRP web application needed to be designed
such that many users can run projects
simultaneously. Consequently, we wanted a avoid
situations where a single user could consume a large
portion of the web server’s resources. The ImiRP
application stops generating mutant sequences once
at least five valid mutants have been identified for
each independent region or once the Sequence
Mutation module has effectively exhausted all
mutation possibilities. This ensures that a single
mutation request will not continue to process
unnecessary sequences and continue to consume
resources. Due to the Sequence Mutation module
generating mutations faster than the Target Site
Prediction module can scan them; it is possible that
more than five valid mutations may be identified.
Only five valid mutant sequences are displayed for
each independent region in the results tab of the
output user interface. If a user is interested in having
all valid mutations displayed, they can download the
source code and run the application on their own
machine.
Generation of mutant sequences
We made several attempts to devise an algorithm that
would not generate duplicate mutant sequences or mu-
tants that did not satisfy all criteria. In an attempt at
preventing duplicate mutations, a sequential permuta-
tion generation strategy was used. However, this ap-
proach was subject to spending long time periods
generating undesirable mutants. For some problems, the
sequential approach finds solutions very quickly while
with others it does not find any solutions within a feas-
ible time period. The random approach was found to
more reliably and consistently produce results across a
diverse set of mutation problems.
We also initially attempted to develop a mutation gen-
eration algorithm that would only generate mutant
sequences that satisfy all specified criteria without wast-
ing computation on generating mutants that do not.
This approach was abandoned because it was both diffi-
cult to make such algorithms and they would require the
development of new mutation generation algorithms for
every set of criteria. As such, we decided it was prefera-
ble to keep separate the concepts of mutant sequence
generation and criteria selection, thus enabling the user
to specify diverse mutation criteria. For projects requir-
ing disruption of a large number of target sites and hav-
ing relatively simple criteria, it may be preferable to
devise a mutation generation algorithm that does not re-
quire the additional filtering step. An example of simple
criteria is: mutations must introduce two nucleotide sub-
stitutions per site using any of the four nucleotides.
Whereas an example of more complex requirements is:
mutations must introduce at least two nucleotide substi-
tutions, nucleotide substitutions must be adjacent and
must not contain guanosine. However, if disruption of
one or a few sites is desired, these inefficiencies do not
appreciably impact processing speed.
Testing the ImiRP target site predictor and mutation
generator
To determine whether ImiRP could accurately predict
miRNA target sites, we input 150 nucleotide segments
from human, mouse and fly 3’UTR sequences and com-
pared output predictions for wild type sequences to pre-
dictions generated by TargetScan [3] and PITA [23] for
the same sequences (Additional file 1: Figure S4). All
3’UTR sequence data was collected using the University
of California, Santa Cruz (UCSC) genome browser [36].
Care was taken when making comparisons to PITA’s
predictions. As of the first release of ImiRP, PITA’s data-
base of mature miRNA sequences, obtained from miR-
Base version 11.0, is out of date. Additionally, PITA’s
seed site prediction logic is not based on the currently
accepted seed site classification [12]. Consequently, ma-
ture miRNA sequences available through miRBase were
used to verify PITA’s seed site type predictions. Our re-
sults show that ImiRP is capable of accurately predicting
8mer, 7mer-m8, 7mer-A1 and 6mer seed sites. One limi-
tation of these tests is that TargetScan and PITA do not
recognize OS-6mer seed sites. However, manual com-
parison between ImiRP’s OS-6mer seed predictions and
mature miRNA sequences in miRBase reveals that
ImiRP is capable of correctly predicting OS-6mer seed
sites (data not shown). Target site prediction output for
three sample 3’UTR sequences is provided in Additional
file 1: Figure S4.
To test the program’s capacity to successfully intro-
duce mutations into many sites simultaneously, while
also ensuring that new predicted target sites for other
miRNAs were not created, we used the aforementioned
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150 nucleotide 3’UTR sequences and target site predic-
tions as input into ImiRP. We compared the ImiRP’s tar-
get site prediction output between the wild type and
mutant sequences to ensure that specified target sites
were successfully mutated and that new sites were not
created. Sample output for a 150 nucleotide segment
from mouse Pax6 3’UTR containing six predicted target
sites is shown in Additional file 1: Figure S5.
Software limitations
Though ImiRP is capable of identifying predicted illegit-
imate miRNA target sites created following mutation of
existing target sites, this software does not identify mRNA
regulatory elements required for non-miRNA processes.
For example, the process of introducing mutations into a
3’UTR sequence could create an RNA-binding protein
motif or abolish a pre-existing polyadenylation signal. A
freely available web application called Transterm could be
used to address this shortcoming [37]. Transterm can
identify protein binding sites in mRNA 3’UTRs, and thus
a user could compare Transterm results between their ori-
ginal input and mutant 3’UTR sequences to ensure that
no known motifs had been created or disrupted. In future
versions of ImiRP, we may implement a tool that identifies
known polyadenylation signal motifs, and ensures that
polyadenylation signals present in the input sequence are
not disrupted and new polyadenylation signals are not cre-
ated following mutation.
One limitation associated with identifying only five clas-
ses of target seed site is that other seed site types have been
identified that may also be functional. In vivo reporter as-
says suggest that 4mer and 5mer seed sites also having ex-
tensive complementarity to the miRNA 3’ end can be
functional [28]. However other studies investigating
miRNA-dependent repression in vivo demonstrate that
5mer seed matches, complementary to miRNA positions 2-
6, could not mediate repression [38]. As a consequence, we
designed the ImiRP target site predictor such that it does
not identify 4mer or 5mer target site types. Genome-wide
miRNA-mRNA interaction maps from mouse brain gener-
ated by Argonaute High-Throughput Sequencing of RNA
isolated by crosslinking immunoprecipitation (Ago HITS-
CLIP) also suggest that two additional target site types may
exist. A third type of 6mer target site, 6merα (complemen-
tary to miRNA position 1-6), is capable of binding Ago-
miRNA [39]. Additionally, miRNA recognition elements
containing G nucleotide bulges at positions 5-6 in the
mRNA (G-bulge sites) are evolutionarily conserved and
functional in vivo [38]. ImiRP is currently incapable of iden-
tifying 6merα and G-bulge target sites and, as a conse-
quence, these site types may be created upon mutation of
existing sites. Based on user demand, we may choose to en-
able identification of 6merα and G-bulge sites though the
ImiRP target site predictor.
Often, experiments designed to disrupt a specific se-
quence motif remove the sequence by deletion as opposed
to mutating several nucleotides. The software could be de-
signed to permit deletion mutations as well, however this
would significantly complicate illegitimate target site iden-
tification. ImiRP compares target site predictions between
the input and mutant sequences. Any predicted target
sites that are shared between the input and mutant se-
quences, i.e. target sites for the same miRNA, located at
the same position within the sequence, are not considered
illegitimate. Information about the position of a predicted
target site within the sequence is critical for identifying le-
gitimate versus illegitimate target sites. Enabling deletion
mutations will require a more complicated illegitimate tar-
get site identification algorithm. We plan to enable the
use of insertion and deletion mutations as part of ImiRP’s
mutagenesis strategies in future versions. For the time be-
ing, users can download the ImiRP source code and mod-
ify it to enable insertion/deletion mutations.
Unfortunately, it is challenging to predict with certainty
whether a miRNA target site has successfully been abol-
ished by mutation without experimentation. Based on pre-
vious experimental evidence [28], introducing at least two
nucleotide changes into the mRNA region complementary
to miRNA positions 2-7 is likely to abolish regulation by
the targeting miRNA. Similarly, predicting the functionality
of a newly created miRNA target sites is also challenging
without experimental validation. For example, a known lys-
6 site from the cog-1 3’UTR in C. elegans is often nonfunc-
tional when transplanted into different 3’UTR contexts
[35]. ImiRP provides information about all illegitimate tar-
get sites created in the output mutant sequence. Available
databases documenting validated miRNA-target interac-
tions [40–42] and known miRNA expression profiles [43–
45] could be used to assist in determining whether
illegitimate target site predictions are likely to occur.
Conclusion
In summary, we have described ImiRP, software that en-
ables mutation of one or more predicted miRNA target
sites within a sequence of interest while ensuring that new
predicted target sites for other miRNAs are not created in
the process. The ImiRP input interface allows the user to
input a sequence of interest and specify the location of one
or more target sites to mutate, species of interest, invalid
target site types, and mutation strategy. The output inter-
face allows the user to select a desired mutant for each in-
dependent region, and view a finalized mutant sequence.
Upon completion, the assembled mutant sequence, and
miRNA target site predictions for the input and mutant se-
quences are made available for download. ImiRP source
code is accessible open source through GitHub (https://
github.com/imirp) under the Apache Version 2 license, and
is available as a web application at imirp.org.
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